Other obesity associated biomarkers worthy of prospective investigation into the effects of weight loss strategies on MetS-OA include RBP4, LOX-1 and the associated adipokines and inflammatory markers, as discussed. The gene discussed is RBP4; the disease is obesity due to melanocortin 4 receptor deficiency.